Now available to watch on-demand.
Cardiac biomarkers are a vital bridge between the clinical laboratory and real-world clinical impact. This educational webinar will explore how high-sensitivity troponin and natriuretic peptides are revolutionizing the diagnosis and management of cardiovascular disease.
Join Dr. Louise Cullen, Professor of Medicine and Emergency Physician along with Dr. James Januzzi, Professor of Medicine at Harvard Medical School and Chief Scientific Officer of the Baim Institute as they examine how immunoassay technologies are enabling faster and more accurate diagnosis, and more personalized care.
They will discuss the use of high-sensitivity troponin for rapid diagnosis of acute myocardial infarction (AMI) as well as how it could be used as a tool for risk stratification after cardiac presentation to the ED, including for those not diagnosed at that time with an AMI.
Additionally, they will highlight the benefits of using natriuretic peptides for heart failure diagnosis in the ED and outpatient settings, outlining when to use BNP or NT-proBNP to support diagnosis and ongoing cardiac care.
Designed for lab professionals and clinicians, this webinar will spotlight the critical role of laboratory diagnostics in transforming cardiac care worldwide.
Key learning objectives:
- Identify possible ways to support patient populations that have signs and symptoms of acute coronary syndrome (ACS) and elevated troponin levels but have been ruled out for AMI.
- Identify the key challenges of employing a rapid rule-out algorithm and how to overcome them.
- Understand when and how to use NT-proBNP or BNP for heart failure diagnosis in the ED and outpatient settings.
Who should attend?
Healthcare professionals, cardiologists, clinical staff, lab technicians, lab directors, laboratorians, pathologists, researchers, and academics.
Presenters
Dr. Louise Cullen
Professor of Medicine
Emergency Physician
Dr. James Januzzi
Professor of Medicine, HMS
CSO, Baim Institute
Sarah Thomas
Associate Editor
SelectScience